Similar articles

• Phosphate and 1alpha-hydroxyvitamin D3 therapy in haemodialysis patients.

  Davison AM, Peacock M, Walker GS, Marshall DH, McLaughlin MS, Robinson PJ. Davison AM, et al. Clin Endocrinol (Oxf). 1977 Dec;7 Suppl:91s-99s. doi: 10.1111/j.1365-2265.1977.tb03368.x. Clin Endocrinol (Oxf). 1977. PMID: 606431 No abstract available.
• Bone disease and hyperparathyroidism in chronic renal failure: the effect of 1alpha-hydroxyvitamin D3.

  Peacock M, Aaron JE, Walker GS, Davison AM. Peacock M, et al. Clin Endocrinol (Oxf). 1977 Dec;7 Suppl:73s-81s. doi: 10.1111/j.1365-2265.1977.tb03365.x. Clin Endocrinol (Oxf). 1977. PMID: 606428 No abstract available.
• Minor influence of parathyroid hormone on fractional tubular reabsorption of phosphate in chronic renal failure.

  Christensen MS, Brochner-Mortensen J, Tougaard L, Sorensen E, Rodbro P. Christensen MS, et al. Adv Exp Med Biol. 1977;81:131-9. doi: 10.1007/978-1-4613-4217-5_15. Adv Exp Med Biol. 1977. PMID: 899922
• Current status of the use of 1,25(OH)2D3 in the management of renal osteodystrophy.

  Massry SG, Goldstein DA, Malluche HH. Massry SG, et al. Kidney Int. 1980 Oct;18(4):409-18. doi: 10.1038/ki.1980.154. Kidney Int. 1980. PMID: 7014981 Review. No abstract available.
• [Vitamin D metabolism and chronic kidney insufficiency].

  Schaefer K, von Herrath D, Kraft D. Schaefer K, et al. Dtsch Med Wochenschr. 1973 Jul 6;98(27):1338-44. doi: 10.1055/s-0028-1107026. Dtsch Med Wochenschr. 1973. PMID: 4351844 Review. German. No abstract available.